Alyeska Investment Group, L.P. Health Catalyst, Inc. Transaction History
Alyeska Investment Group, L.P.
- $18 Billion
- Q3 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,158,230 shares of HCAT stock, worth $8.2 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,158,230
Previous 984,560
17.64%
Holding current value
$8.2 Million
Previous $6.29 Million
49.85%
% of portfolio
0.05%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding HCAT
# of Institutions
170Shares Held
49.7MCall Options Held
2.86MPut Options Held
56.4K-
Black Rock Inc. New York, NY5.43MShares$38.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.58MShares$32.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN4.3MShares$30.4 Million3.05% of portfolio
-
Impax Asset Management Group PLC2.55MShares$18.1 Million0.09% of portfolio
-
Daventry Group, LP New York, NY2.42MShares$17.1 Million7.83% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $387M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...